Trials / Completed
CompletedNCT03299855
MoCA vs. MMS: Which Tool to Detect Cognitive Disorders in Oncogeriatric?
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 104 (actual)
- Sponsor
- Centre Francois Baclesse · Academic / Other
- Sex
- All
- Age
- 70 Years
- Healthy volunteers
- Not accepted
Summary
This study concerns elderly patients with cancer with onco-geriatric assessment. This study propose to associate the collection of the results with the Mini-Cog and the CODEX with the passing of the MoCA and the MMS tests, as well as a neuropsychological assessment, in order to determine if the patients have cognitive impairments, to evaluate the sensitivity of these 4 screening tests in elderly patients seeking treatment for their cancer. The results of this study will make it possible, where appropriate, to adapt the practice in the context of oncogeriatric assessment.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Passation of neuropsychological test | Passation of MoCA and MMS tests associated with neuropsychological test |
Timeline
- Start date
- 2017-10-13
- Primary completion
- 2023-10-13
- Completion
- 2023-10-13
- First posted
- 2017-10-03
- Last updated
- 2023-10-18
Locations
6 sites across 1 country: France
Source: ClinicalTrials.gov record NCT03299855. Inclusion in this directory is not an endorsement.